EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Role of Ryanodine Receptor 2 Polymorphisms in Oral Squamous Cell Carcinoma Susceptibility and Clinicopathological Features

Ching-Hui Hsu, San-Fu Hong, Yu-Sheng Lo, Hsin-Yu Ho iD, Chia-Chieh Lin iD, Yi-Ching Chuang, Ming-Ju Hsieh iD, Ming-Chih Chou

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms251910328 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Ching-Hui Hsu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Head and Neck Surgery, Changhua Christian Hospital, Changhua 500, Taiwan. Hauptthemen laut MEDLINE: Ryanodine Receptor Calcium Release Channel, Polymorphism, Single Nucleotide, Genetic Predisposition to Disease, Mouth Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Head and neck squamous cell carcinoma (HNSCC) is the sixth most common malignancy worldwide, and oral squamous cell carcinoma (OSCC) is one of the most common types. There is strong evidence that ryanodine receptor 2 (RYR2) plays an important role in different types of cancer according to previous studies. Its expression is associated with survival in patients with HNSCC, but it is unknown whether altered RYR2 expression contributes to tumorigenesis. Therefore, we examined how RYR2 polymorphisms affect OSCC susceptibility and clinicopathological characteristics. Five single nucleotide polymorphisms (SNPs) of RYR2, rs12594, rs16835904, rs2779359, rs3765097, and rs3820216, were analyzed in 562 cases of OSCC and 332 healthy controls using real-time PCR. We demonstrated that RYR2 SNP rs12594 was significantly different between the case and control groups, but this difference was not significant after adjusting for personal habits. In contrast, we found that different genotypes of SNP rs2779359 were significantly associated with the characteristics of clinical stage and tumor size in OSCC patients, according to the odds ratios and the adjusted odds ratios; specifically, patients with the T genotype had 1.477-fold (95% CI, 1.043 to 2.091; p = 0.028) and 1.533-fold (95% CI, 1.087–2.162; p = 0.015) increases in clinical stage and tumor size, respectively, compared with patients with the C allele. The results of our study, in which RYR2 SNPs associated with OSCC progression and development were examined for the first time, suggest that clinicopathological characteristics may alter OSCC susceptibility. Finally, RYR2 SNP rs2779359 not only plays a role in both the prognosis and diagnosis of oral cancer but is also likely an important predictive factor for recurrence, response to treatment, and medication toxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ryanodine Receptor Calcium Release ChannelPolymorphism, Single NucleotideGenetic Predisposition to DiseaseMouth NeoplasmsCarcinoma, Squamous CellHumansMaleFemaleMiddle AgedCase-Control StudiesAgedAdultGenotypeSquamous Cell Carcinoma of Head and NeckNeoplasm Staging

Stichwörter der Autor:innen

head and neck squamous cell carcinomasoral squamous cell carcinomasryanodine receptor 2single nucleotide polymorphisms

Substanzen

Ryanodine Receptor Calcium Release ChannelRyR2 protein, human

Autor:innen und Institutionen

  • Department of Otorhinolaryngology, Head and Neck Surgery, Changhua Christian Hospital, Changhua 500, Taiwan.
  • Institute of Medicine, Chung Shan Medical University, Taichung 402, Taiwan.
  • Oral Cancer Research Center, Changhua Christian Hospital, Changhua 500, Taiwan.
  • Graduate Institute of Clinical Medicine, College of Medicine, National Chung Hsing University, Taichung 402, Taiwan.
  • Graduate Institute of Biomedical Sciences, China Medical University, Taichung 404, Taiwan.
  • Division of Thoracic Surgery, Department of Surgery, Chung Shan Medical University Hospital, Taichung 402, Taiwan.

ORCID-Profile: Hsin-Yu Ho, Chia-Chieh Lin, Ming-Ju Hsieh

Zitieren

APA

Hsu, C. H., Hong, S. F., Lo, Y. S., Ho, H. Y., Lin, C. C., Chuang, Y. C., Hsieh, M. J., & Chou, M. C. (2024). The Role of Ryanodine Receptor 2 Polymorphisms in Oral Squamous Cell Carcinoma Susceptibility and Clinicopathological Features. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms251910328

Vancouver

Hsu CH, Hong SF, Lo YS, Ho HY, Lin CC, Chuang YC, et al. The Role of Ryanodine Receptor 2 Polymorphisms in Oral Squamous Cell Carcinoma Susceptibility and Clinicopathological Features. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms251910328

BibTeX
@article{Hsu2024,
  author = {Hsu, Ching-Hui and Hong, San-Fu and Lo, Yu-Sheng and Ho, Hsin-Yu and Lin, Chia-Chieh and Chuang, Yi-Ching and Hsieh, Ming-Ju and Chou, Ming-Chih},
  title = {The Role of Ryanodine Receptor 2 Polymorphisms in Oral Squamous Cell Carcinoma Susceptibility and Clinicopathological Features},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms251910328}
}
Kostenlos starten →